TY - JOUR
T1 - Contemporary Risk of Surgery in Patients With Ulcerative Colitis and Crohn's Disease
T2 - A Meta-Analysis of Population-Based Cohorts
AU - Tsai, Lester
AU - Ma, Christopher
AU - Dulai, Parambir S.
AU - Prokop, Larry J.
AU - Eisenstein, Samuel
AU - Ramamoorthy, Sonia L.
AU - Feagan, Brian G.
AU - Jairath, Vipul
AU - Sandborn, William J.
AU - Singh, Siddharth
N1 - Funding Information:
Funding Supported by an American Gastroenterological Association Career Development Award (P.S.D.), a National Institute of Diabetes and Digestive and Kidney Diseases?funded San Diego Digestive Diseases Research Center (P30 DK120515) (W.J.S.), National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (K23DK117058), an American College of Gastroenterology Junior Faculty Development Award (144271), and a Crohn's and Colitis Foundation Career Development Award (404614) (S.S.).
Publisher Copyright:
© 2021
PY - 2021/10
Y1 - 2021/10
N2 - Background & Aims: We conducted a systematic review with meta-analysis to estimate rates and trends of colectomy in patients with ulcerative colitis (UC), and of primary and re-resection in patients with Crohn's disease (CD), focusing on contemporary risks. Methods: Through a systematic review until September 3, 2019, we identified population-based cohort studies that reported patient-level cumulative risk of surgery in patients with UC and CD. We evaluated overall and contemporary risk (after 2000) of surgery and analyzed time trends through mixed-effects meta-regression. Results: In patients with UC (26 studies), the overall 1-, 5-, and 10-year risks of colectomy was 4.0% (95% CI, 3.3–5.0), 8.8% (95% CI, 7.7–10.0), and 13.3% (95% CI, 11.3–15.5), respectively, with a decrease in risk over time (P <.001). Corresponding contemporary risks were 2.8% (95% CI, 2.0–3.9), 7.0% (95% CI, 5.7–8.6), and 9.6% (95% CI, 6.3–14.2), respectively. In patients with CD (22 studies), the overall 1-, 5-, and 10-year risk of surgery was 18.7% (95% CI, 15.0–23.0), 28.0% (95% CI, 24.0–32.4), and 39.5% (95% CI, 33.3–46.2), respectively, with a decrease in risk over time (P <.001). Corresponding contemporary risks were 12.3% (95% CI, 10.8–14.0), 18.0% (95% CI, 15.4–21.0), and 26.2% (95% CI, 23.4–29.4), respectively. In a meta-analysis of 8 studies in patients with CD with prior resection, the cumulative risk of a second resection at 5 and 10 years after the first resection was 17.7% (95% CI, 13.5–22.9) and 31.3% (95% CI, 24.1–39.6), respectively. Conclusions: Patient-level risks of surgery have decreased significantly over time, with a 5-year cumulative risk of surgery of 7.0% in UC and 18.0% in CD in contemporary cohorts. This decrease may be related to early detection and/or better treatment.
AB - Background & Aims: We conducted a systematic review with meta-analysis to estimate rates and trends of colectomy in patients with ulcerative colitis (UC), and of primary and re-resection in patients with Crohn's disease (CD), focusing on contemporary risks. Methods: Through a systematic review until September 3, 2019, we identified population-based cohort studies that reported patient-level cumulative risk of surgery in patients with UC and CD. We evaluated overall and contemporary risk (after 2000) of surgery and analyzed time trends through mixed-effects meta-regression. Results: In patients with UC (26 studies), the overall 1-, 5-, and 10-year risks of colectomy was 4.0% (95% CI, 3.3–5.0), 8.8% (95% CI, 7.7–10.0), and 13.3% (95% CI, 11.3–15.5), respectively, with a decrease in risk over time (P <.001). Corresponding contemporary risks were 2.8% (95% CI, 2.0–3.9), 7.0% (95% CI, 5.7–8.6), and 9.6% (95% CI, 6.3–14.2), respectively. In patients with CD (22 studies), the overall 1-, 5-, and 10-year risk of surgery was 18.7% (95% CI, 15.0–23.0), 28.0% (95% CI, 24.0–32.4), and 39.5% (95% CI, 33.3–46.2), respectively, with a decrease in risk over time (P <.001). Corresponding contemporary risks were 12.3% (95% CI, 10.8–14.0), 18.0% (95% CI, 15.4–21.0), and 26.2% (95% CI, 23.4–29.4), respectively. In a meta-analysis of 8 studies in patients with CD with prior resection, the cumulative risk of a second resection at 5 and 10 years after the first resection was 17.7% (95% CI, 13.5–22.9) and 31.3% (95% CI, 24.1–39.6), respectively. Conclusions: Patient-level risks of surgery have decreased significantly over time, with a 5-year cumulative risk of surgery of 7.0% in UC and 18.0% in CD in contemporary cohorts. This decrease may be related to early detection and/or better treatment.
KW - Disease Modification
KW - Inflammatory Bowel Diseases
KW - Natural History
KW - Resection
KW - Tumor Necrosis Factor
UR - http://www.scopus.com/inward/record.url?scp=85103375417&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85103375417&partnerID=8YFLogxK
U2 - 10.1016/j.cgh.2020.10.039
DO - 10.1016/j.cgh.2020.10.039
M3 - Review article
C2 - 33127595
AN - SCOPUS:85103375417
VL - 19
SP - 2031-2045.e11
JO - Clinical Gastroenterology and Hepatology
JF - Clinical Gastroenterology and Hepatology
SN - 1542-3565
IS - 10
ER -